Home / Share Price Target / Shilpamed
Shilpa Medicare Share Price Target 2024, 2025, 2026 to 2039 With Charts
Shilpa Medicare Limited | |||
Symbol: SHILPAMED | |||
Price: ₹936 | |||
Exchange: NSE | |||
Healthcare -> Drug Manufacturers - Specialty & Generic |
Show Table of Contents
Table of Contents
- 1: Shilpa Medicare Brief Company Overview
- 1.1: Shilpa Medicare Limited: A Global Healthcare Leader
- 1.2: Shilpa Medicare Financial Performance
- 1.2.1: Is Shilpa Medicare A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Shilpa Medicare Share Price Target For 2024
- 2.1.1: Shilpa Medicare Share Price Target Table For 2024
- 2.1.2: Summary: Shilpa Medicare Share Price Prediction For 2024
- 2.2: Shilpa Medicare Share Price Target For 2025
- 2.2.1: Shilpa Medicare Share Price Target Table For 2025
- 2.2.2: Summary: Shilpa Medicare Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Shilpa Medicare Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Shilpa Medicare Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Shilpa Medicare Past Performance
Shilpa Medicare Brief Company Overview
Shilpa Medicare Limited: A Global Healthcare Leader
Founded in 1987, Shilpa Medicare Limited has established itself as a prominent player in the pharmaceutical industry. The company's diverse product portfolio includes oncology and non-oncology APIs, new drug delivery systems, peptides/biotech products, and specialty chemicals.
With operations spanning India, the United States, Europe, and other international markets, Shilpa Medicare has a global footprint. The company's commitment to quality and innovation is reflected in its contract manufacturing services for a variety of dosage forms.
Shilpa Medicare's reputation in the industry is built on its high standards of manufacturing and adherence to regulatory compliance. The company's commitment to research and development ensures that it remains at the forefront of innovation in the healthcare sector.
Shilpa Medicare Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 4,894.43 Crore | Market valuation of Shilpa Medicare's shares. |
Revenue (TTM) | 1,124.75 Crore | Total revenue generated by Shilpa Medicare over the past twelve months. |
Net Income (TTM) | -67.06 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 13.69% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | -0.06% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +9.1% | Change in revenue compared to the previous quarter. |
Debt-to-Equity (D/E) Ratio | 48.76 | Company's total debt divided by total shareholder equity. |
Total Debt | 865.43 Crore | Sum of Shilpa Medicare's current & long-term financial obligations. |
Total Cash | 23.97 Crore | Total amount of liquid funds available to Shilpa Medicare. |
Beta | 0.77 | Beta is less than 1 indicating that the Shilpa Medicare's price is less volatile than the market. |
Is Shilpa Medicare A Good Buy For Long Term?
Shilpa Medicare's recent financial data indicates mixed signals. While its past performance and revenue growth have been impressive, its negative net profit and high debt raise concerns. The low profit margin suggests operational inefficiencies. For long-term investment, investors may want to consider more financially stable companies with consistent profitability and lower debt levels.
To predict the Shilpa Medicare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Shilpa Medicare Share Price Target For 2024
The line chart displays the monthly closing prices of Shilpa Medicare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Shilpa Medicare shares in 2024, see the table below.
Shilpa Medicare Share Price Target Table For 2024
Shilpa Medicare's Levels | Value | Reason/Importance |
---|---|---|
2024 Target 3 | 917.70 (-1.96%) | Price Action: Nov 2024 High |
2024 Target 2 | 903.36 (-3.49%) | Custom Fibonacci Extension Lvl 50% |
2024 Target 1 | 887.90 (-5.14%) | Price Action: 17 Oct 2024 High |
Current Price | 936.00 | Shilpa Medicare's 1 share price as of Thu 21 Nov 2024 |
Stop Loss 1 | 876.79 (-6.33%) | Price Action: Chart |
Stop Loss 2 | 864.09 (-7.69%) | Price Action: 21 Oct 2024 High |
Stop Loss 3 | 854.00 (-8.77%) | Price Action: 30 Oct 2024 High |
Summary: Shilpa Medicare Share Price Prediction For 2024
In summary, Shilpa Medicare has surged by ₹605.70, achieving a notable +183.38% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Shilpa Medicare for 2024 predicts an additional rise of -5.14% to -1.96% by the end of 2024 with three potential targets T1: 887.90, T2: 903.36, T3: 917.70. Stop Loss at SL1: 876.79, SL2: 864.09, SL3: 854.00.
Shilpa Medicare has a 52-week high of ₹959.50, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹313.14, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Shilpa Medicare.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Shilpa Medicare Share Price Target For 2025
The line chart displays the monthly closing prices of Shilpa Medicare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Shilpa Medicare shares in 2025, see the table below.
Shilpa Medicare Share Price Target Table For 2025
Shilpa Medicare's Levels | Value | Reason/Importance |
---|---|---|
2025 Target 3 | 1309.65 (+39.91%) | Price Action: Chart |
2025 Target 2 | 1285.23 (+37.31%) | Price Action: Chart |
2025 Target 1 | 1272.50 (+35.95%) | Custom Fibonacci Extension Lvl 64.9% |
Current Price | 936.00 | Shilpa Medicare's 1 share price as of Thu 21 Nov 2024 |
Stop Loss 1 | 789.90 (-15.61%) | Price Action: 22 Oct 2024 Low |
Stop Loss 2 | 780.04 (-16.67%) | Price Action: 23 Oct 2024 Low |
Stop Loss 3 | 765.09 (-18.26%) | Price Action: 28 Oct 2024 Low |
Summary: Shilpa Medicare Share Price Prediction For 2025
In summary, Shilpa Medicare has surged by ₹605.70, achieving a notable +183.38% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Shilpa Medicare for 2025 predicts an additional rise of 35.95% to 39.91% by the end of 2025 with three potential targets T1: 1272.50, T2: 1285.23, T3: 1309.65. Stop Loss at SL1: 789.90, SL2: 780.04, SL3: 765.09.
Shilpa Medicare has a All-Time high of ₹959.50, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹313.14, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Shilpa Medicare, we have created a specific page for that check here: Shilpa Medicare Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Shilpa Medicare Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Shilpa Medicare share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 17.53% over the next 15 years.
For complete year by year Shilpa Medicare long term share price target from 2024, 2025 to 2039 check the below table.
Shilpa Medicare Share Price Target Table From 2024, 2025, 2026 to 2039
Year | Shilpa Medicare Target | YoY Change % |
---|---|---|
2024 | ₹936 | [Current Price] |
2024 | ₹1,053.85 | 12.59% |
2025 | ₹1,643.88 | 55.98% |
2026 | ₹2,244.41 | 36.53% |
2027 | ₹3,035.54 | 35.24% |
2028 | ₹3,788.17 | 24.79% |
2029 | ₹4,350.07 | 14.83% |
2030 | ₹4,806.89 | 10.5% |
2031 | ₹5,362.86 | 11.56% |
2032 | ₹6,336.04 | 18.14% |
2033 | ₹7,171.3 | 13.18% |
2034 | ₹7,646.28 | 6.62% |
2035 | ₹7,969.92 | 4.23% |
2036 | ₹8,481.31 | 6.41% |
2037 | ₹9,636.54 | 13.62% |
2038 | ₹10,554.44 | 9.52% |
2039 | ₹10,118.34 | -4.14% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Shilpa Medicare Past Performance
- In 2005, Shilpa Medicare opening price was ₹7.4
- As of Thu 21 Nov 2024 the price stands at ₹936.
- This represents a Compound Annual Growth Rate (CAGR) of 27.38%.
- In 19 years, an investment of 10,000 would have become ₹12.64 Lakh.
As we wrap up, we hope you like our study on Shilpa Medicare share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Shilpa Medicare Share Price History
- Shilpa Medicare Price Target Tomorrow
- Shilpa Medicare Dividend History
- Shilpa Medicare Bonus History
- Shilpa Medicare Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.